Annual Net Margin
N/A
December 31, 2023
Summary
- SEEL annual net profit margin is not available.
Performance
SEEL Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Net Margin
N/A
June 30, 2024
Summary
- SEEL quarterly net profit margin is not available.
Performance
SEEL Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
SEEL Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
SEEL Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Seelos Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | -393.12%(+67.1%) | -88.70%(-77.6%) |
| Sep 2015 | - | -395.44%(-65.2%) |
| Jun 2015 | - | -1135.28%(-15.9%) |
| Mar 2015 | - | -1349.89%(+48.9%) |
| Dec 2014 | -235.30%(-65.1%) | -906.55%(+452.7%) |
| Sep 2014 | - | -164.01%(-576.5%) |
| Jun 2014 | - | 34.42%(-109.3%) |
| Dec 2013 | -674.55%(+68.7%) | -371.55%(-96.5%) |
| Sep 2013 | - | -10.66 K%(+3129.3%) |
| Jun 2013 | - | -330.12%(-64.6%) |
| Mar 2013 | - | -933.58%(+13.0%) |
| Dec 2012 | -399.89%(-31.1%) | -826.13%(+1521.5%) |
| Sep 2012 | - | -50.95%(-100.0%) |
| Jun 2012 | - | -164.20 K%(>+9900.0%) |
| Mar 2012 | - | -603.46%(+117.3%) |
| Dec 2011 | -580.67%(-2.1%) | - |
| Sep 2011 | - | -277.75%(-43.2%) |
| Jun 2011 | - | -488.61%(+127.3%) |
| Mar 2011 | - | -214.93%(-83.4%) |
| Dec 2010 | -593.36%(-44.9%) | -1293.25%(+440.6%) |
| Sep 2010 | - | -239.22%(-17.8%) |
| Jun 2010 | - | -290.88%(-54.5%) |
| Mar 2010 | - | -638.94%(-93.7%) |
| Dec 2009 | -1077.53%(+1141.4%) | -10.21 K%(+840.0%) |
| Sep 2009 | - | -1086.43%(-21.8%) |
| Jun 2009 | - | -1389.84%(-5106.6%) |
| Mar 2009 | - | 27.76%(-14.7%) |
| Dec 2008 | -86.80%(-87.5%) | 32.56%(-103.3%) |
| Sep 2008 | - | -993.68%(+631.9%) |
| Jun 2008 | - | -135.77%(-21.3%) |
| Mar 2008 | - | -172.54%(-74.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | -691.71%(+60.6%) | -667.62%(-4.1%) |
| Sep 2007 | - | -695.83%(-1.0%) |
| Jun 2007 | - | -702.51%(-1.1%) |
| Mar 2007 | - | -710.66%(+44.7%) |
| Dec 2006 | -430.83%(-33.1%) | -490.99%(+10.2%) |
| Sep 2006 | - | -445.44%(+132.4%) |
| Jun 2006 | - | -191.67%(-70.1%) |
| Mar 2006 | - | -640.23%(+371.6%) |
| Dec 2005 | -643.66%(-86.4%) | -135.75%(-99.9%) |
| Sep 2005 | - | -127.59 K%(-32.1%) |
| Jun 2005 | - | -188.01 K%(-3.2%) |
| Mar 2005 | - | -194.22 K%(+11.1%) |
| Dec 2004 | -4737.09%(-69.6%) | -174.83 K%(+2252.4%) |
| Sep 2004 | - | -7432.20%(+247.5%) |
| Jun 2004 | - | -2138.60%(-44.0%) |
| Mar 2004 | - | -3821.12%(-74.9%) |
| Dec 2003 | -15.56 K%(-16.7%) | -15.23 K%(+209.0%) |
| Sep 2003 | - | -4929.12%(-98.8%) |
| Jun 2003 | - | -409.19 K%(+103.1%) |
| Mar 2003 | - | -201.48 K%(-26.5%) |
| Dec 2002 | -18.67 K%(-21.4%) | -274.05 K%(+3016.0%) |
| Sep 2002 | - | -8794.88%(-72.7%) |
| Jun 2002 | - | -32.19 K%(+161.3%) |
| Mar 2002 | - | -12.32 K%(-100.0%) |
| Dec 2001 | -23.76 K%(-100.0%) | - |
| Dec 2000 | -883.01 M%(>+9900.0%) | - |
| Sep 2000 | - | -184.26 M%(-25.4%) |
| Jun 2000 | - | -246.92 M%(+99.4%) |
| Mar 2000 | - | -123.82 M% |
| Dec 1999 | -168.05%(+100.8%) | - |
| Dec 1998 | -83.71%(-98.8%) | - |
| Dec 1997 | -6866.87% | - |
FAQ
- What is the all time high annual net margin for Seelos Therapeutics?
- What is the all time high quarterly net margin for Seelos Therapeutics?
What is the all time high annual net margin for Seelos Therapeutics?
Seelos Therapeutics all-time high annual net profit margin is -83.71%
What is the all time high quarterly net margin for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly net profit margin is 34.42%